CRISPR

CRISPR2-dmrt1

ID

ZDB-CRISPR-200630-1

Name

CRISPR2-dmrt1

Previous Names

None

Target

dmrt1 (1)

Sequence

5' - GGCGGTGGCACTGCTGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
umo15	dmrt1

Expression

Gene expression in Wild Types + CRISPR2-dmrt1

No data available

Phenotype

Phenotype resulting from CRISPR2-dmrt1

No data available

Phenotype of all Fish created by or utilizing CRISPR2-dmrt1

Phenotype	Fish	Conditions	Figures
female organism ratio male organism, abnormal	dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 4 from Wu et al., 2020
female organism increased amount, abnormal	dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 1 from Wu et al., 2020
male organism decreased amount, abnormal	dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 1, Fig. 4 from Wu et al., 2020
blood estradiol decreased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/+ (AB)	standard conditions	Fig. 1 from Wu et al., 2020
male organism estradiol decreased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/+ (AB)	standard conditions	Fig. 1 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 1 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 1 from Wu et al., 2020
blood estradiol decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+ (AB)	standard conditions	Fig. 1 from Wu et al., 2020
female organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+ (AB)	standard conditions	Fig. 1 from Wu et al., 2020
male organism estradiol decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+ (AB)	standard conditions	Fig. 1 from Wu et al., 2020
female organism ratio male organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+ (AB)	standard conditions	Fig. 1 from Wu et al., 2020
ovarian follicle stage IV decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 2 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 1 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 1 from Wu et al., 2020
blood estradiol decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 1 from Wu et al., 2020
ovarian follicle stage II increased size, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 2 from Wu et al., 2020
ovarian follicle stage III decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 2 from Wu et al., 2020
male organism estradiol decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15 (AB)	standard conditions	Fig. 1 from Wu et al., 2020
male organism increased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
female organism decreased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism increased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism decreased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism ratio male organism, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism increased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
female organism increased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
ovarian follicle degenerate, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism increased amount, abnormal	cyp19a1a^umo5/+; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism ratio male organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism increased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
female organism ratio male organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism increased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
female organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism ratio male organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism increased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/+; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
female organism increased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism increased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/+; esr2a^umo12/+; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
female organism increased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/+	standard conditions	Fig. 4 from Wu et al., 2020
male organism ratio female organism, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
ovarian follicle degenerate, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
male organism decreased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020
female organism increased amount, abnormal	cyp19a1a^umo5/umo5; dmrt1^umo15/umo15; esr1^umo10/umo10; esr2a^umo12/umo12; esr2b^umo13/umo13	standard conditions	Fig. 4 from Wu et al., 2020

Citations